Skip to main content
Premium Trial:

Request an Annual Quote

Egyptian Biotech Group Seeks 'Omics Partners

NEW YORK (GenomeWeb News) – The Egyptian Organization for Biotechnology and Vaccines is seeking partners to work with it on a variety of research program areas focused largely on genotyping and pharmacogenetics in cancer and in autoimmune diseases, the European Commission said this week.

The Cairo-based lab seeks partners for collaborative projects of small, medium, and large scales that could involve a range of research areas.

These projects could involve research into pharmacogenomics and pharmacogenetics research; bioinformatics; epigenetic applications in gene therapy for autoimmune diseases; epigenetic applications in gene therapy for autoimmune disease; human molecular diseases that could include DNA-based technologies; developing real-time PCR for quantifying gene expression related to diabetes, cancer, and leukemia; and proteomics and metabolomics applications of disease treatment, among others.

More information about the partnership request is available at the European Commission’s Seventh Framework Program website.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.